Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer

J.Ko; Y.Kim; M.Park; Z.Cui; M.Ahn; K.Park

首页> 外文期刊>European Journal of Cancer Supplements >Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer

【24h】

Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer

机译：EGFR-TKI诱导EGFR突变型非小细胞肺癌细胞死亡和耐药的机制

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第9期|共2页
作者
J.Ko; Y.Kim; M.Park; Z.Cui; M.Ahn; K.Park;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer [J] . J.Ko, Y.Kim, M.Park, European Journal of Cancer Supplements . 2008,第9期

机译：EGFR-TKI诱导EGFR突变型非小细胞肺癌细胞死亡和耐药的机制
2. Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs [J] . Choong-kun Lee, Sora Kim, Jae Seok Lee, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2017,第期

机译：下一代测序揭示了具有抗预测抗EGFR-TKIS的EGFR-突变体非小细胞肺癌中的新抗性机制和分子异质性
3. Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway [J] . Hongyan Wu, Fangtian Fan, Zhaoguo Liu, Cancer chemotherapy and pharmacology. . 2015,第2期

机译：Norcantharidin结合EGFR-TKIs通过抑制Met / PI3k / Akt途径克服了HGF诱导的EGFR突变型肺癌细胞对EGFR-TKIs的耐药性
4. Towards the Mechanism of EGFR Inhibitor Resistance in Non-Small Lung Cancer Cells [C] . Michael Blank, Ryan Bomgarden, John Rogers, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：朝向非小肺癌细胞EGFR抑制剂抗性的机制
5. Analyzing the Impact of EGFR-induced c-Met Phosphorylation in Non-Small Cell Lung Cancer. [D] . Dulak, Austin M. 2010

机译：分析EGFR诱导的c-Met磷酸化对非小细胞肺癌的影响。
6. Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance [O] . Ruoshuang Han, Yijun Jia, Xuefei Li, 2021

机译：二甲双胍的同时使用egfr-tkis在高级Egfr-突变体非小细胞肺癌患者中提高EGFR-TKI的功效 - 一种克服EGFR-TKI抗性的选择
7. Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M. [O] . Kwang Sup So, Cheol Hyeon Kim, Jin Kyung Rho, 2014

机译：由CK2抑制剂诱导的自噬体介导的EGFR下调增强了EGFR-TKI对具有T790m抗性的EGFR突变肺癌细胞的功效。

Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer

著录项

相似文献

相关主题

期刊订阅